A.M. Snelling
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 9
-
- Vibrio bacteria research studies 3
- Enterobacteriaceae and Cronobacter Research 3
- Escherichia coli research studies 2
- Co-authors
- K.G. Kerr (1 shared paper)D M Chalmers (2 shared papers)ATR Axon (2 shared papers)John Heritage (8 shared papers)Peter M. Hawkey (8 shared papers)Harald Seifert (1 shared paper)Deborah Gascoyne‐Binzi (2 shared papers)J.I. Ross (3 shared papers)
- Journals
- Journal of Clinical Microbiology (4 papers)British Journal of Dermatology (2 papers)The Lancet (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Journal of Hospital Infection (2 papers)
- Partner nations
- United KingdomGermanyNepal
In The Last Decade
A.M. Snelling
17 papers receiving 2.4k citations
A.M. Snelling's Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Medicine 743
- Endocrinology 437
- Dermatology 353
- Applied Microbiology and Biotechnology 77
- Gastroenterology 117
Countries citing papers authored by A.M. Snelling
This map shows the geographic impact of A.M. Snelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Snelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Snelling more than expected).
Fields of papers citing papers by A.M. Snelling
This network shows the impact of papers produced by A.M. Snelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Snelling. The network helps show where A.M. Snelling may publish in the future.
Co-authors
The 25 scholars most cited alongside A.M. Snelling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Hit paper breakdown → | 1999 | 809 |
| 2 | 2009 | 409 | |
| 3 | 1998 | 367 | |
| 4 | 2003 | 266 | |
| 5 | 1996 | 156 | |
| 6 | 2001 | 109 | |
| 7 | 1996 | 96 | |
| 8 | 1998 | 70 | |
| 9 | 1994 | 63 | |
| 10 | 2010 | 42 | |
| 11 | 1998 | 27 | |
| 12 | 2006 | 25 | |
| 13 | 2010 | 20 | |
| 14 | 1998 | 14 | |
| 15 | 1993 | 9 | |
| 16 | Characterisation of ocular isolates of Haemophilus influenzae from Saudi Arabia | 2002 | 2 |
| 17 | 1999 | 2 |
About A.M. Snelling
A.M. Snelling is a scholar working on Molecular Medicine, Endocrinology, Epidemiology, Molecular Biology and Dermatology, having authored 17 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Acne and Rosacea Treatments and Effects (3 papers), Vibrio bacteria research studies (3 papers), Enterobacteriaceae and Cronobacter Research (3 papers), Bacterial biofilms and quorum sensing (2 papers), Escherichia coli research studies (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Aquaculture disease management and microbiota (1 paper). The work is most often cited by research in Molecular Medicine (743 citations), Endocrinology (437 citations), Dermatology (353 citations), Applied Microbiology and Biotechnology (77 citations) and Gastroenterology (117 citations). A.M. Snelling has collaborated with scholars based in United Kingdom, Germany and Nepal. Frequent co-authors include K.G. Kerr, D M Chalmers, ATR Axon, John Heritage, Peter M. Hawkey, Harald Seifert, Deborah Gascoyne‐Binzi, J.I. Ross, E. Anne Eady and Jonathan H. Cove. Their work appears in journals such as Journal of Clinical Microbiology, British Journal of Dermatology, The Lancet, Journal of Antimicrobial Chemotherapy and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.